tegafur has been researched along with Chemotherapy-Induced Acral Erythema in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The existing studies suggest that S-1 is not more effective than capecitabine in the treatment of gastric cancer patients, but does exhibit less toxicity with regard to hand-foot syndrome." | 4.91 | Efficacy of S-1 vs capecitabine for the treatment of gastric cancer: a meta-analysis. ( Dong, WG; He, AB; Luo, RF; Peng, XL; Song, J; Tang, Y; Zhang, JX, 2015) |
| "We selected 186 patients with gastric cancer who underwent D2 resection in Hangzhou First People's Hospital and Hangzhou Cancer Hospital from June 2014 to June 2017." | 1.51 | A two centers study of postoperative adjuvant chemotherapy with S-1 versus SOX/XELOX regimens for gastric cancer after D2 resection: a cohort study. ( Lu, Y; Sun, Y; Wang, Z; Zheng, S; Zhou, Y, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuda, K | 1 |
| Namiki, T | 1 |
| Ueno, M | 1 |
| Hashimoto, T | 1 |
| Hanafusa, T | 1 |
| Yokozeki, H | 1 |
| Kwakman, JJM | 2 |
| van Werkhoven, E | 1 |
| Simkens, LHJ | 1 |
| van Rooijen, JM | 1 |
| van de Wouw, YAJ | 1 |
| Tije, AJT | 1 |
| Creemers, GM | 1 |
| Hendriks, MP | 1 |
| Los, M | 1 |
| van Alphen, RJ | 1 |
| Polée, MB | 1 |
| Muller, EW | 1 |
| van der Velden, AMT | 1 |
| van Voorthuizen, T | 1 |
| Koopman, M | 1 |
| Mol, L | 1 |
| Punt, CJA | 2 |
| Zheng, S | 1 |
| Zhou, Y | 1 |
| Sun, Y | 1 |
| Wang, Z | 1 |
| Lu, Y | 1 |
| He, AB | 1 |
| Peng, XL | 1 |
| Song, J | 1 |
| Zhang, JX | 1 |
| Dong, WG | 1 |
| Luo, RF | 1 |
| Tang, Y | 1 |
| Baars, A | 1 |
| Boot, H | 1 |
| Pruijt, JFM | 1 |
| Winther, SB | 1 |
| Pfeiffer, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| S1 Versus Capecitabine in the First Line Treatment of Metastatic Colorectal Cancer Patients, the SALTO Randomised Phase III Study of the Dutch Colorectal Cancer Group. A Safety Evaluation of Oral Fluoropyrimidines[NCT01918852] | Phase 3 | 161 participants (Actual) | Interventional | 2013-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for tegafur and Chemotherapy-Induced Acral Erythema
| Article | Year |
|---|---|
Efficacy of S-1 vs capecitabine for the treatment of gastric cancer: a meta-analysis.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chi-S | 2015 |
1 trial available for tegafur and Chemotherapy-Induced Acral Erythema
| Article | Year |
|---|---|
Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colorectal Neoplasm | 2019 |
3 other studies available for tegafur and Chemotherapy-Induced Acral Erythema
| Article | Year |
|---|---|
Tegafur/gimeracil/oteracil (TS-1)-induced erythroderma with an extensive mucosal involvement and hand-foot syndrome.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colonic Neop | 2017 |
A two centers study of postoperative adjuvant chemotherapy with S-1 versus SOX/XELOX regimens for gastric cancer after D2 resection: a cohort study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; China; Cohort | 2019 |
Tolerability of the oral fluoropyrimidine S-1 after hand-foot syndrome-related discontinuation of capecitabine in western cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Capecitabine; Denmark; Drug Combinations; Drug Substitution; Female; | 2017 |